A synthetic peptide for use as a blocking control in assays to test for specificity of NCKAP1 L antibody, Alternative Names: NCKAP1L control peptide, NCKAP1L antibody Blocking Peptide, Anti-NCKAP1L Blocking Peptide, NCK-associated protein 1-like Blocking Peptide, HEM1 Blocking Peptide, NCKAP1L, NCKAPL-1, NCKAPL 1, NCKAPL-1 Blocking Peptide, NCKAPL 1 Blocking Peptide
Aufreinigung
The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
NCKAP1L
(NCK-Associated Protein 1-Like (NCKAP1L))
Hintergrund
NCKAP1L is a member of the HEM family of tissue-specific transmembrane proteins which are highly conserved from invertebrates through mammals. This gene is only expressed in hematopoietic cells, while hematopoietic protein 2 is preferentially expressed in brain, heart, liver and testis. The function of the HEM1 product has not been established but it is thought to play an essential role in oogenesis.